Pet Bird Health Market Trends, Growth & Research Report to 2033

According to the UnivDatos, increasing pet bird ownership, advancements in avian veterinary medicine, and growing awareness of avian health drive the Pet Bird Health market. As per their Pet Bird Health Market report, the global market was valued at USD 0.93 billion in 2024, growing at a CAGR of about 6.14% during the forecast period from 2025 - 2033 to reach USD billion by 2033.

The Pet Bird Health is witnessing remarkable growth due to the increasing pet bird ownership, advancements in avian veterinary medicine, and growing awareness of avian health continues are driving the market growth. Some of the key companies leading the charge in the manufacturing, processing, and supply of Pet Bird Health products and services have been mentioned below.

Access sample report (including graphs, charts, and figures):https://univdatos.com/reports/pet-bird-health-market?popup=report-enquiry

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, laboratory products, and biopharma services in North America, Europe, Asia-Pacific, and internationally. The companys Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services.It also providesAvian (Bird/Poultry) Diagnostic Solutions for diseases in pet birds, such as Avian influenza, Avian mycoplasmosis, Avian metapneumovirus, and Newcastle disease (ND).

Founded	1956
Headquarter	Waltham,United States
Employees	125,000
Revenue (2024)	42,879.0 USD Millions

Merck Co., Inc.

Merck Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. It provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands.

Founded	1891
Headquarter	Rahway,United States
Employees	74,000
Revenue (2024)	64,168.0 USD Millions

VioVet Ltd.

VioVet Ltd. operates as an online retailer of pet food, medication, toys, and equestrian supplies in the United Kingdom. It sells a range of foods, medication, and care products for dogs and cats; prescription medication, supplements, food balancers, fly rugs, and tack and stable products for horses; and products for various types of birds ranging from canary food to parrot food to layers pellets for chickens, parrot cages, hen homes, and nest boxes for wild birds, as well as disinfectants and health supplements for birds, bird wormers, and medications.

Founded	2006
Headquarter	Luton,United Kingdom
Employees	107
Revenue (2024)	59.2 USD Millions

INDICAL BIOSCIENCE GmbH (Vimian Group AB)

INDICAL BIOSCIENCE GmbH manufactures diagnostic workflows for veterinary laboratories. The company was founded in 1996 and is based in Leipzig, Germany. INDICAL BIOSCIENCE GmbH operates as a subsidiary of QIAGEN Deutschland Holding GmbH and Vimian Group AB. The company provides the diagnostic kit named Virotype Influenza A H5/H7/H9 RT-PCR Kit for the simultaneous detection and differentiation of RNA from Avian Influenza Virus H5/H7/H9.

Founded	1996
Headquarter	Leipzig,Germany
Employees	29
Revenue (2024)	20.1 USD Millions

Click here to view the Report Description TOChttps://univdatos.com/reports/pet-bird-health-market

AdvaCare Pharma

AdvaCare Pharma USA LLC manufactures pharmaceuticals, antimalarials, oncology solutions, supplements, veterinary products, and medical devices. The company offers tablets, capsules, soft-gels, liquid injections, powder for injections, syrups, creams, ointments, nasal sprays, eye drops, ear drops, boluses, oral suspensions, granules, and premixes. It serves distributors, hospitals, and governments. AdvaCare Pharma USA LLC was incorporated in 2014 and is based in Cheyenne, Wyoming. AdvaCare Pharma is a reputable manufacturer of veterinary medicine for birds. Its extensive range includes antibiotic, antiparasitic, and nutritional bird medications for many common health problems.